The Hilary Martindale Shaw
International Patients Program
Literature, news and videos pertinent to
The Hilary Martindale Shaw International Patients Program
PAPILLON: Adding Amivantamab to First-Line Chemotherapy Prolongs Progression-Free Survival in NSCLC Subset
By The ASCO Post Staff
December 10, 2023 - Supplement: ESMO Highlights
National Lung Screening Trial Results Highlight Importance of Lifelong Follow-up
By The ASCO Post Staff
October 10, 2022 - Supplement: Conference Highlights IASLC 2022
Screening for Lung Cancer with Low Dose Computed Tomography (LDCT)—CMS.gov Centers for Medicare & Medicaid Services
INHERIT EGFR - Studying Germline EGFR Mutations (INHERIT) —ClinicalTrials.gov
The Hilary Martindale Shaw International Patients Program
is a vital part of ICAN's Personalized Medicine and Direct Navigation Services and is dedicated to exon 20 insertion patients.
For more information about this special program, please click on...
Federal Tax I.D.: EIN 86-0818253 | WA Charities: 37195